References
- Garcia HH, Del Brutto OH. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol.4(10), 653–661 (2005).
- Del Brutto OH, Sotelo J, Roman GC. Neurocysticercosis. A Clinical Handbook. Swets and Zeitliger, Lisse, The Netherlands (1997).
- Robles C, Chavarria Chavarria M. [Report of a clinical case of cerebral cysticercosis treated medically with a new drug: praziquantel]. Salud. Publica. Mex.21(5), 603–618 (1979).
- Botero D, Castano S. Treatment of cysticercosis with praziquantel in Colombia. Am. J. Trop. Med. Hyg.31(4), 811–821 (1982).
- Sotelo J, Escobedo F, Rodriguez-Carbajal J, Torres B, Rubio-Donnadieu F. Therapy of parenchymal brain cysticercosis with praziquantel. N. Engl. J. Med.310(16), 1001–1007 (1984).
- Spina-Franca A, Nobrega JP, Livramento JA, Machado LR. Administration of praziquantel in neurocysticercosis. Tropenmed. Parasitol.33(1), 1–4 (1982).
- Vazquez ML, Jung H, Sotelo J. Plasma levels of praziquantel decrease when dexamethasone is given simultaneously. Neurology37(9), 1561–1562 (1987).
- Corona T, Lugo R, Medina R, Sotelo J. Single-day praziquantel therapy for neurocysticercosis. N. Engl. J. Med.334(2), 125 (1996).
- Pretell EJ, Garcia HH, Custodio N et al. Short regimen of praziquantel in the treatment of single brain enhancing lesions. Clin. Neurol. Neurosurg.102(4), 215–218 (2000).
- Pretell EJ, Garcia HH, Gilman RH, Saavedra H, Martinez M; The Cysticercosis Working Group in Peru. Failure of one-day praziquantel treatment in patients with multiple neurocysticercosis lesions. Clin. Neurol. Neurosurg.103, 175–177 (2001).
- Escobedo F, Penagos P, Rodriguez J, Sotelo J. Albendazole therapy for neurocysticercosis. Arch. Intern. Med.147(4), 738–741 (1987).
- Sotelo J, del Brutto OH, Penagos P et al. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. J. Neurol.237(2), 69–72 (1990).
- Sotelo J, Penagos P, Escobedo F, Del Brutto OH. Short course of albendazole therapy for neurocysticercosis. Arch. Neurol.45(10), 1130–1133 (1988).
- Garcia HH, Gilman RH, Horton J et al. Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. Neurology48(5), 1421–1427 (1997).
- Matthaiou DK, Panos G, Adamidi ES, Falagas ME. Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trials. PLoS Negl. Trop. Dis.2(3), e194 (2008).
- Nash TE, Neva FA. Recent advances in the diagnosis and treatment of cerebral cysticercosis. N. Engl. J. Med.311(23), 1492–1496 (1984).
- Garcia HH, Pretell EJ, Gilman RH et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N. Engl. J. Med.350(3), 249–258 (2004).